Key result
This review outlines the current state of heart valve tissue engineering, discussing mechanical and biological replacement options, biomaterials, cells, bioreactors, and technological hurdles.
This review provides an overview of the current state of heart valve tissue engineering, including biomaterials, cells, bioreactors, and technological hurdles.
No takes yet. Share an insight, caveat, or question.
Heart valve tissue engineering remains preclinical; leaves open optimization of cells, scaffolds, and bioreactors before any clinical translation.
Migneco et al. (2008) reported a review. Heart valve tissue engineering was evaluated. This review outlines the current state of heart valve tissue engineering, discussing mechanical and biological replacement options, biomaterials, cells, bioreactors, and technological hurdles.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: